Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Title
Intervention Indication Therapeutic Area Year Actions
Bempedoic acid (monotherapy) or bempedoic acid in combination with ezetimibe for primary hypercholesterolaemia or mixed dyslipidaemia Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Bempedoic acid (monotherapy) and bempedoic acid/ezetimibe (fixed-dose combination) for primary hypercholesterolaemia or mixed dyslipidaemia Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
bb2121 for Relapsed and Refractory Multiple Myeloma Idecabtagene vicleucel (Ide-cel; bb2121) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2018 View  |  Download
Baloxavir marboxil for treatment of influenza A or B infection in otherwise healthy patients aged 12 years and older Baloxavir marboxil (Xofluza; S-033188) Influenza Infectious Disease 2018 View  |  Download
Axitinib for Patients at High Risk of Recurrence of Renal Cell Carcinoma – Adjuvant Axitinib (Inlyta; AG-013736) Renal cell carcinoma (RCC) Renal Cancer 2018 View  |  Download
Axalimogene Filolisbac for Cervical Cancer – Beyond First Line Treatment Axalimogene filolisbac (ADXS11-001) Cervical cancer Female Reproductive Cancer 2018 View  |  Download
AVXS-101 for spinal muscular atrophy Onasemnogene abeparvovec (Zolgensma; AVXS-101; scAAV9.CB.SMN) Spinal muscular atrophy (SMA) Genetic Disorders , Musculoskeletal System 2018 View  |  Download
Avelumab with or without Pegylated Liposomal Doxorubicin (PLD) for Ovarian Cancer – second line Avelumab (Bavencio; MSB-0010718C) , Pegylated liposomal doxorubicin Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer Female Reproductive Cancer 2018 View  |  Download
Avelumab in combination with axitinib for advanced or metastatic renal cell carcinoma – first line Avelumab (Bavencio; MSB-0010718C) , Axitinib (Inlyta; AG-013736) Renal cell carcinoma (RCC) Renal Cancer 2018 View  |  Download
Avacopan in addition to standard of care for ANCA-associated vasculitis Avacopan (CCX168) Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) Cardiovascular System , Immunology 2018 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications